Fat (Mesenchymal Tissue)
- What is the difference between the GCell® SVF procedure and PRP?
PRP (Platelet Rich Plasma) means platelet-rich plasma obtained from one’s own blood by centrifugation. It attracts the cells that will repair the damaged tissue to the site of application.
These necessary cells are left directly to the applied area with the application of the GCell® SVF, and regeneration is targeted in addition to the repair of the old/ damaged tissue. Thus, regeneration is achieved more quickly and livingly.
2. Where can the GCell® be applied?
It can be easily applied under polyclinic conditions/in the clinical setting, as long as sterilization is taken into account. Of course, if desired, it can also be performed in operating rooms such as surgery.
3. How much oil does the new Generation ‘GCell®’ Fat Tissue Suspension system
require?
While it is necessary to take 100-150 cc of oil in existing systems, with this new technology (GCell®)
only 15 cc of oil is sufficient.
4. Is the number of mesenchymal stem cells obtained with the GCell® application sufficient?
Although only 15 ccs of fat was removed, according to the cell count results of Marmara University GEMHAM; it has been proven that there are more than 2.2 million mesenchymal stem cells in 1 ml in the final product. This result is the optimum value for the application.
5. Is there a side effect of the GCell® procedure?
Since the GCell® system is a 100% autologous application, no side effects are expected.
Old/damaged tissue is regenerated with the patient’s own cells.
- Is liposuction performed to obtain fat in GCell® procedure?
No, in the GCell® application, we aspirate only 15 ccs of fat using a special cannula. - Is local anesthesia efficient for GCell® application?
In this application, the block anesthesia method is applied. Since the procedure is performed only in a certain area, local anesthesia is sufficient. Therefore, it does not require a team for anesthesia. - What distinguishes the GCell® protocol from stem cell systems derived from existing adipose tissue?
Why is this new system in need of development?
First of all,100-150 ccs tumescent is injected into the area where the fat will be removed first in order to remove the fat from the person in the existing systems. This treatment should be performed in order for the final product to be injectable in the existing systems. However, it then requires a washing process. Because in the final product to be made, the given tumescence should be separated from the fat tissues. However, there is no study proving that it is purified from the tumescence until the last product is obtained after all these washing and centrifugation procedures. With the new generation GCell® SVF application, the process takes less time since only 15 ccs of oil is sufficient. Moreover, this process is very reliable since there is no different substance between the oil taken 100% autologously. Again, according to the results of Marmara University GEMHAM cell count, the rate of living cells in the final product is 98%. The living cell rate is almost 100%.
- Does the New Generation GCell® technology differ technically from existing systems?
The GCell® technology has integrated both photo activation and homogenization processes into its own system. Thus, it offers different processes in a single device. Thanks to the photo activation
process, activated stem cells are directly applied to the tissue. Thus, the time taken for normal
stem cells to be activated by entering the body is not lost. Thanks to
the homogenization process, there is a similar amount of stem cells
in each ml to be applied.
10. In which areas do you prefer the GCell® procedure and when can the patients return to their daily life?
Antiaging is preferred for the purpose of increasing skin brightness and lifting. In addition, it is applied as a combined monotherapy with the aim of supporting hair transplantation in female and male patients
with androgenetic alopecia who have hair loss. The patients can continue
their daily life after approximately 1 hour of operation.
